en.Wedoany.com Reported - NNB Nutrition and Axiom Foods have announced a partnership to bring PeptiClear™, a next-generation plant protein technology, to the global food industry, offering an alternative to tight whey protein supplies. NNB has also launched DL-185®, a dietary dileucine peptide designed to enhance the anabolic potential of plant protein formulations.
The food industry's demand for protein has expanded beyond sports nutrition into nearly every category, including beverages, snacks, ice cream, baked goods, confectionery, and everyday functional foods. This ongoing "proteinization" has significantly driven up global demand for high-quality protein ingredients, particularly whey protein. However, whey supply is directly tied to dairy and cheese production, and its supply chain cannot rapidly scale to meet surging market demand.
Against this backdrop, manufacturers worldwide are facing mounting pressure from tightening supply, rising costs, and intensified competition for inventory. Large multinational food companies, leveraging their purchasing power and long-term contracts, can still secure supply, while emerging brands and smaller manufacturers encounter higher barriers when entering high-protein categories. The partnership between NNB and Axiom Foods aims to alleviate this tension. Axiom Foods also supplies plant-based protein milk, which can serve as a substitute for dairy protein.
Unlike traditional plant proteins that may carry off-flavors, gritty textures, or opacity, PeptiClear™ hydrolyzed plant protein offers a more neutral flavor profile, improved functionality, and exceptional solubility. This highly concentrated, clear protein ingredient can be applied to a wide range of products where conventional plant proteins fall short, including functional beverages, ready-to-drink products, ice cream and frozen desserts, condiments and salad dressings, sauces, confectionery, baked goods, high-protein snacks, and everyday functional foods.
NNB's DL-185® consists of two leucine molecules naturally linked in peptide form and can be incorporated into dietary supplements and foods just like leucine. Human clinical studies show that DL-185® stimulates muscle protein synthesis approximately 60% more than leucine; another human clinical study involving resistance-trained individuals demonstrated that DL-185® supplementation produced greater strength improvements than an equivalent amount of leucine. When paired with PeptiClear™, this combination aims to close the performance gap traditionally seen in plant protein formulations.
Dustin Elliott, Chief Brand Officer at NNB, stated that the future of protein is not about replacing whey, but about expanding the world's ability to deliver high-quality protein across various food formats. As consumer demand continues to outpace traditional dairy supply, the industry needs innovative solutions that balance functionality, scalability, and performance.
NNB Nutrition focuses on nutraceutical ingredient innovation, with precision-engineered molecules as its core approach, rather than relying on traditional extraction or commoditized sourcing. The company has filed over 60 patent applications and brought more than a dozen new ingredients to market. Related studies were published in J Appl Physiol (2021, Vol. 131, Issue 3, pp. 1111-1122) and PLoS ONE (2024, Vol. 19, Issue 12, e0312997).
